Russell NH, Hills RK, Kjeldsen L, Clark RE, et al. A randomised comparison of FLAG-Ida versus daunorubicin combined with clofarabine in relapsed or refractory acute myeloid leukaemia: Results from the UK NCRI AML17 trial. Br J Haematol 2022;198:528-534.
PMID: 35388465